Back to search

Georgia Institute of Technology

Hydrogel-based co-delivery of lysostaphin and rifampin eliminates a chronic infection and promotes healing of bone defects

Abstract

dc:description.abstract

In this project, we engineered a synthetic poly(ethylene glycol)-based hydrogel for the encapsulation and delivery of lysostaphin and rifampin to the site of infection to facilitate infection mitigation and fracture healing in bone defect models. PEG-maleimide hydrogels were reacted with the collagen-mimetic cell adhesive peptide GFOGER and cross-linked with the protease-degradable crosslinker VPM to encapsulate the antimicrobial agents. In conjunction with systemic antibiotics, our antimicrobial hydrogels showed significant mitigation of a chronic infection in a femoral fracture model, both with intramedullary pin fixation and plate fixation hardware, as well as in methicillin-susceptible and methicillin-resistant strains of S. aureus. Mice receiving the hydrogel containing lysostaphin and local antibiotics also exhibited a more robust callus and bone formation compared to the untreated control with the addition of BMP-2. Additionally, the local inflammatory response was characterized for these antimicrobial hydrogels, and results showed a downregulation of the expression of most pro-inflammatory cytokines. Immune cell profiling gave further insights into the host response to these hydrogels and showed that lysostaphin and rifampin gels reduced neutrophil and macrophage infiltration to the site of infection, as well as showed improvement in T cell infiltration and exhaustion in comparison to untreated infections. We then sought to translate this platform into an ovine model to provide a more clinically relevant scenario of orthopedic hardware infection within bone defects. An acute infection study was performed in which an ulnar bone defect with an acute infection was treated with hydrogels either with or without lysostaphin. Results showed significantly lower bacterial counts in the treated groups versus the untreated. Additionally, a metapodial bone defect containing an established infection was created to assess the potential of co-delivery of lysostaphin and local antibiotics within the hydrogel platform. This work provides a novel platform for antimicrobial delivery that not only mitigates chronic infections in a wide variety of clinically relevant scenarios, but also promotes bone healing and resolution of the host inflammatory response.

Degree

thesis:*
Level thesis:degree_level
Doctoral
Department dc:contributor.department
Mechanical Engineering
Grantor dc:publisher
Georgia Institute of Technology
Year dc:date.issued
2023

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Caplin, Jeremy David
Advisor dc:contributor.advisor
  • García, Andrés J.
Committee members dc:contributor.committeemember
  • Botchwey, Edward A.
  • Donlan, Rodney M.
  • Willett, Nick
  • Peroni, John F.

Subjects

dc:subject × 6

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/1853/75060

Chain of custody

source
Harvested from
Georgia Tech
Base URL
repository.gatech.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Caplin, Jeremy David. Hydrogel-based co-delivery of lysostaphin and rifampin eliminates a chronic infection and promotes healing of bone defects. Doctoral thesis, Georgia Institute of Technology, 2023. https://hdl.handle.net/1853/75060